Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergei N Pokrovsky

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Lipidology|May 24, 2016
Lipoprotein(a) apheresisSergei N Pokrovsky, Olga I Afanasieva, Marat V Ezhov
Current Atherosclerosis Reports|September 18, 2020
Therapeutic Apheresis for Management of Lp(a) HyperlipoproteinemiaSergei N Pokrovsky, Olga I Afanasieva, Marat V Ezhov
Biomolecules|February 13, 2021
Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs ArteriesMarat V Ezhov, Narek A Tmoyan, Olga I Afanasieva, et al.
Diseases (Basel, Switzerland)|February 26, 2026
Lipoprotein(a) Concentration and Achieving Target Values of Low-Density Lipoprotein Cholesterol Calculated by Different EquationsOlga I Afanasieva, Alexandra V Tyurina, Elena A Klesareva, et al.
Journal of Clinical Apheresis|September 3, 2014
Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresisMaya S Safarova, Marat V Ezhov, Olga I Afanasieva, et al.
Atherosclerosis|June 22, 2014
Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass graftingMarat V Ezhov, Maya S Safarova, Olga I Afanasieva, et al.
Diseases (Basel, Switzerland)|February 28, 2022
Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia DiagnosisUliana V Chubykina, Marat V Ezhov, Olga I Afanasieva, et al.
Atherosclerosis|October 2, 2018
Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemiaOlga I Afanasieva, Marat V Ezhov, Oksana A Razova, et al.
Diseases (Basel, Switzerland)|October 24, 2023
Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart DiseaseOlga I Afanasieva, Alexandra V Tyurina, Marat V Ezhov, et al.
International Journal of Molecular Sciences|October 29, 2025
Role of Lipoprotein(a) and Blood Cells Ratios in Peripheral Artery DiseaseAlexandra V Tyurina, Olga I Afanasieva, Marat V Ezhov, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Lipidology|May 24, 2016
Lipoprotein(a) apheresisSergei N Pokrovsky, Olga I Afanasieva, Marat V Ezhov
Current Atherosclerosis Reports|September 18, 2020
Therapeutic Apheresis for Management of Lp(a) HyperlipoproteinemiaSergei N Pokrovsky, Olga I Afanasieva, Marat V Ezhov
Biomolecules|February 13, 2021
Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs ArteriesMarat V Ezhov, Narek A Tmoyan, Olga I Afanasieva, et al.
Diseases (Basel, Switzerland)|February 26, 2026
Lipoprotein(a) Concentration and Achieving Target Values of Low-Density Lipoprotein Cholesterol Calculated by Different EquationsOlga I Afanasieva, Alexandra V Tyurina, Elena A Klesareva, et al.
Journal of Clinical Apheresis|September 3, 2014
Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresisMaya S Safarova, Marat V Ezhov, Olga I Afanasieva, et al.
Atherosclerosis|June 22, 2014
Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass graftingMarat V Ezhov, Maya S Safarova, Olga I Afanasieva, et al.
Diseases (Basel, Switzerland)|February 28, 2022
Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia DiagnosisUliana V Chubykina, Marat V Ezhov, Olga I Afanasieva, et al.
Atherosclerosis|October 2, 2018
Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemiaOlga I Afanasieva, Marat V Ezhov, Oksana A Razova, et al.
Diseases (Basel, Switzerland)|October 24, 2023
Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart DiseaseOlga I Afanasieva, Alexandra V Tyurina, Marat V Ezhov, et al.
International Journal of Molecular Sciences|October 29, 2025
Role of Lipoprotein(a) and Blood Cells Ratios in Peripheral Artery DiseaseAlexandra V Tyurina, Olga I Afanasieva, Marat V Ezhov, et al.
Pageof 2